Related Experiment Video
Updated: Aug 10, 2026
04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
Repeat hepatectomy for recurrent colorectal liver metastases
Patrick Pessaux1, Emilie Lermite, Olivier Brehant
1Department of Digestive Surgery, Chu Angers, Angers, France. pessauxpchuangers@yahoo.fr
Journal of Surgical Oncology
|December 15, 2005
Summary
Repeat liver resection offers long-term survival for metastatic colorectal cancer (MCC) patients, comparable to initial surgeries. Key prognostic factors include CEA levels, extrahepatic disease, and tumor size.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastrointestinal Oncology
Background:
- Liver resection is the primary curative treatment for metastatic colorectal cancer (MCC).
- Recurrence after initial resection is common, often limited to the liver.
- Identifying effective treatments for recurrent MCC is crucial.
Purpose of the Study:
- To evaluate the efficacy of repeat liver resection for recurrent MCC.
- To identify prognostic factors predicting survival after repeat hepatectomies.
Main Methods:
- Retrospective review of 42 patients undergoing 55 repeat hepatectomies (second, third, or fourth) between 1992 and 2002.
- Analysis of patient demographics, primary tumor characteristics (colon vs. rectum), and metastasis timing (synchronous).
Main Results:
- No intraoperative or postoperative mortality; morbidity rates were comparable across repeat hepatectomies.
- Overall 5-year survival rates were 33% (first), 21% (second), and 36% (third) hepatectomies.
- Predictive factors for survival included serum CEA levels, extrahepatic disease, and tumor size >5 cm.
Conclusions:
- Repeat hepatectomies can achieve long-term survival rates similar to initial liver resections for MCC.
- Prognostic factors identified can aid in patient selection for repeat surgeries.
